Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06374251 · ClinicalTrials.gov registry record · NA
Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers
A NA study of Malignant Digestive System Neoplasm, sponsored by University of Southern California.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
- 1
- Study location
NCT06374251: Completed NA study of Malignant Digestive System Neoplasm, sponsored by University of Southern California.
NCT06374251 is a NA study of Malignant Digestive System Neoplasm that has completed, run by University of Southern California. The registered enrollment target is 8 participants, below the 690-participant average among 11 other Malignant Digestive System Neoplasm trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06374251, a NA study of Malignant Digestive System Neoplasm, has completed, sponsored by University of Southern California.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial assesses whether narrative medicine methods may improve the sense of well-being among gastrointestinal (GI) (digestive system) cancer patients. Narrative medicine is a clinical approach where providers can use a patient's own narrative (perspective) of their illness to promote healing and resilience. By applying narrative medicine's main tool, close reading, to clinical practice, clinicians learn to listen and attend to patients more deeply. This allows for freer communication and the creation of a healthcare encounter that centers on the psychological and emotional well being of the patient in addition to their medical conditions. Narrative medicine can include close reading, creative or reflective writing, and discussion. These methods may help patients with GI cancer to reflect on their life stories, both inside and outside of their illness experience, and help them gather skills to optimize their well-being.
Primary Outcome
To determine the intervention feasibility, the number of participants who complete the narrative medicine sessions will be tracked.
Conditions Studied
Interventions
- OTHER Survey Administration
- OTHER Interview
- PROCEDURE Discussion
Study Locations (1)
California
- USC / Norris Comprehensive Cancer Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-09-27 |
| Est. Completion | 2025-10-21 |
| Phase | NA |
What the finished NCT06374251 record still lists
NCT06374251 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 690-participant average among 11 other Malignant Digestive System Neoplasm trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Malignant Digestive System Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.
NCT06374251 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06374251 about?
NCT06374251 is a clinical study titled "Narrative Medicine for Improving Well-Being in Patients With Gastrointestinal Cancers". This clinical trial assesses whether narrative medicine methods may improve the sense of well-being among gastrointestinal (GI) (digestive system) cancer patients. Narrative medicine is a clinical approach where providers can use a patient's own narrative (perspective) of their illness to promote he...
What is the current status of trial NCT06374251?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2023-09-27. Estimated completion is 2025-10-21.
What conditions does trial NCT06374251 study?
This clinical trial studies the following conditions: Malignant Digestive System Neoplasm.
What interventions are being tested in trial NCT06374251?
The interventions under investigation include: Survey Administration (OTHER), Interview (OTHER), Discussion (PROCEDURE).
Who is sponsoring clinical trial NCT06374251?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06374251 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Digestive System Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06374251's enrollment target sits among peer trials
8 12th of 11 the lowest of 11 other Malignant Digestive System Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Digestive System Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Massage Therapy in Reducing Chemotherapy-Induced Peripheral Neuropathy in Patients With Gastrointestinal or Breast Malignancies
ACTIVE NOT RECRUITING · NA
-
Perioperative Telemonitoring to Optimize Cancer Care and Outcomes
ACTIVE NOT RECRUITING · NA
-
Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal or Gynecological Cancer
RECRUITING · Phase 2
-
Molecular Epidemiology of Biliary Tree Cancers
RECRUITING
-
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
RECRUITING
-
2 Versus 6 Hour Oxaliplatin Infusions in Patients With Gastrointestinal Cancers
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI